Objectives Our primary aim was to describe continuous glucose monitor (CGM) and insulin pump use in youth with T1D with a preferred language of care other than English (LOE) and examine associations between diabetes technology use and hemoglobin A 1c (HbA 1c ) in this population. Methods We assessed baseline technology use for youth with LOE and T1D seen in diabetes clinics at a single center between February 2022 and February 2023. A two-sample t-test was used to compare HbA 1c values between groups. A linear regression model was used to examine differences in HbA 1c between the 3-level technology groups with Tukey-adjusted pairwise comparisons. Results Ninety-four youth with T1D and LOE with complete data on technology use were included in analysis. At baseline 66 % were using diabetes technology with 42 (45 %) using CGM only, 1 (1 %) using insulin pump only, 19 (20 %) using both insulin pump and CGM, and 32 (34 %) not using any technology. HbA 1c was significantly lower in the technology use group (Mean=9.1 %, SD=2.4) compared to the non-technology use group (Mean=10.5 %, SD=2.2) (p=0.01). Conclusions Despite advances in technology for diabetes management, about one-third of youth with T1D and LOE were not using any diabetes technology. Diabetes technology use in this group was associated with lower HbA 1c . Further work should be done to increase diabetes technology use in youth with T1D and LOE.
No takes yet. Share an insight, caveat, or question.
Goldklang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: